D.C. Mun. Regs. tit. 22-A, § 6328
6314
6315
6316
6317
6318
6319
6320
6321
6322
6324
6325
6326
6327
6328.1 All individuals seeking SUD services must be assessed and referred to a particular LOC in accordance with the Department-approved assessment tool(s) and ASAM criteria.
6328.2 Each provider shall ensure that the client receives treatment in accordance with ASAM criteria and this chapter.
6328.3 Each provider shall ensure that all staff comply with all Federal and District laws and regulations pertaining to scope of practice, licensing requirements, and supervision requirements.
6328.4 All treatment shall be:
6328.5 Prior to transitioning to a new LOC, at a minimum, an Ongoing Diagnostic Assessment must be performed to ensure that the client is appropriate for the new LOC.
6328.6 The Clinical Care Coordinator shall ensure appropriate client referrals, authorizations, and transitions to new LOCs.
6328.7 A certified provider shall not deny admission for services to an otherwise
qualified client because that person is receiving MSUD services even if the MSUD services are provided by a different provider.
6328.8 All providers shall offer all Food and Drug Administration (FDA) approved forms of MSUD to any client who meets the criteria for and selects MSUD as part of their Plan of Care, in accordance with certification under this chapter or other Federal and District laws and regulations. If a provider is not certified to offer the client’s choice of medication in accordance with this chapter or under any other Federal and District laws and regulations, then the provider shall refer the client to another provider able to offer MSUD that meets the client’s needs.
SOURCE: Final Rulemaking published at 62 DCR 12056 (September 4, 2015); as amended by Final Rulemaking published at 67 DCR 011585 (October 9, 2020); as amended by Final Rulemaking published at 72 DCR 008497 (August 1, 2025).